BDBM328801 (S)-1,1,1-trifluoro-2- methylpropan-2-yl (4-((1-(2,2- difluoroethyl)-3-ethoxy-1H- pyrazol-4-yl)sulfonyl)-2-((2- hydroxy-2- methylpropanamido)methyl)- 3,4-dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US9663502, 34DC

SMILES CCOc1nn(CC(F)F)cc1S(=O)(=O)N1C[C@H](CNC(=O)C(C)(C)O)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12

InChI Key InChIKey=DGJURPFAHZYBCL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 328801   

TargetNuclear receptor ROR-gamma(Human)
Lycera

US Patent
LigandPNGBDBM328801(US9663502, 34DC | (S)-1,1,1-trifluoro-2- methylpro...)
Affinity DataIC50: 10.3nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., a biochemical TR-FRET assay....More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
US Patent